现有国家抗微生物药物耐药性行动计划分析:优化人类抗微生物药物使用的策略中的差距与机会
该政策分析系统综合了各国针对人类抗微生物药物耐药性的国家行动计划,发现这些计划在政策与战略规划、药物管理与处方系统、优化处方的技术、背景文化与行为、实施交付与监测、患者与公众参与六个领域的成熟度和实施水平存在明显差距和差异,这些差距为促进国家行动计划的可持续实施提供了机会。
要点
- 国家行动计划在六个领域存在成熟度和实施水平的明显差距与差异
- 经济和政治韧性及资源约束的国间差异可能是推进国家行动计划的根本障碍
- 分析结果可用于国家、区域和全球层面识别与基础设施需求相关的优先事项
核心结论
- 国家行动计划在政策与战略规划、药物管理与处方系统、优化处方的技术、背景文化与行为、实施交付与监测、患者与公众参与六个领域存在明显差距和成熟度差异,这些差距为促进可持续实施提供了机会。
研究设计与样本
- 本文为卫生政策类系统证据综合,系统综合了旨在应对人类抗微生物药物耐药性的现有国家行动计划。
主要发现
- 国家行动计划在政策与战略规划领域的成熟度和实施水平存在明显差距和差异。
- 国家行动计划在药物管理与处方系统领域的成熟度和实施水平存在明显差距和差异。
- 国家行动计划在优化抗微生物药物处方的技术领域的成熟度和实施水平存在明显差距和差异。
- 国家行动计划在背景、文化与行为领域的成熟度和实施水平存在明显差距和差异。
- 国家行动计划在实施交付与监测以及患者与公众参与领域的成熟度和实施水平存在明显差距和差异。
临床怎么用
- 分析结果可在国家、区域和全球层面用于识别与基础设施需求和背景相关的抗微生物药物耐药性优先事项。
局限性
- 经济和政治韧性及资源约束的国间差异可能是推进国家行动计划的根本障碍。
- 确保将国家行动计划目标从政策转化为实践的稳健治理结构的可及性仍是主要障碍。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
At the 2015 World Health Assembly, UN member states adopted a resolution that committed to the development of national action plans (NAPs) for antimicrobial resistance (AMR). The political determination to commit to NAPs and the availability of robust governance structures to assure sustainable translation of the identified NAP objectives from policy to practice remain major barriers to progress. Inter-country variability in economic and political resilience and resource constraints could be fundamental barriers to progressing AMR NAPs. Although there have been regional and global analyses of NAPs from a One Health and policy perspective, a global assessment of the NAP objectives targeting antimicrobial use in human populations is needed. In this Health Policy, we report a systematic evidence synthesis of existing NAPs that are aimed at tackling AMR in human populations. We find marked gaps and variability in maturity of NAP development and operationalisation across the domains of: (1) policy and strategic planning; (2) medicines management and prescribing systems; (3) technology for optimised antimicrobial prescribing; (4) context, culture, and behaviours; (5) operational delivery and monitoring; and (6) patient and public engagement and involvement. The gaps identified in these domains highlight opportunities to facilitate sustainable delivery and operationalisation of NAPs. The findings from this analysis can be used at country, regional, and global levels to identify AMR-related priorities that are relevant to infrastructure needs and contexts.
引用
- Charani E, Mendelson M, Pallett SJC, et al. An analysis of existing national action plans for antimicrobial resistance-gaps and opportunities in strategies optimising antibiotic use in human populations. Lancet Glob Health. 2023. PMID: 36739875. doi:10.1016/S2214-109X(23)00019-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。